Close
Show
Home Production & Manufacturing

Production & Manufacturing

Production & Manufacturing

Biovian announces over €50 million investment in manufacturing facility in Turku, Finland

Biovian announces over €50 million investment in manufacturing facility in Turku, Finland


Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a...
New PAT - Based Strategy Stops Membrane Fouling In SP - TFF

New PAT – Based Strategy Stops Membrane Fouling In SP – TFF


A recent article published in the Journal of Membrane Science presents a new approach for...

Cell And Gene Therapy CDMO Services Market Is On The Rise


The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which...

Lack of Experience Hinders CDMOs In Cell And Gene Therapy


CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of...
WHO & Republic of Korea Tie-Up For Biomanufacturing Training

WHO & Republic of Korea Tie-Up For Biomanufacturing Training


The World Health Organisation as well as the Republic of South Korea have gone ahead...
Using Execution Systems to Improve Cell and Gene Therapy Processes

Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition


uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into...

UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia


UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build...
Switzerland To Get A $518mn Fill-Finish Plant From Lonza

Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation


Lonza announces the start of new mid-scale manufacturing assets at its API manufacturing center in...

How ‘First-Time Right’ Formulations Can Help Address the Challenge of Affordable Medicines


For years, global healthcare systems have been facing the triple threat of rising incidences of...

By 2030, OSD Contract Manufacturing Will Be $54.7 Billion


The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion...